Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Feb 13 04:00PM ET
1.63
Dollar change
-0.15
Percentage change
-8.43
%
IndexRUT P/E- EPS (ttm)-21.07 Insider Own50.93% Shs Outstand0.96M Perf Week5.16%
Market Cap3.46M Forward P/E- EPS next Y- Insider Trans-95.25% Shs Float0.59M Perf Month-82.28%
Income-13.64M PEG- EPS next Q- Inst Own4.78% Short Float37.90% Perf Quarter-83.70%
Sales0.00M P/S- EPS this Y- Inst Trans- Short Ratio0.07 Perf Half Y-88.15%
Book/sh-9.50 P/B- EPS next Y- ROA-181.68% Short Interest0.22M Perf Year-99.41%
Cash/sh0.07 P/C23.07 EPS next 5Y- ROE-89.65% 52W Range1.45 - 392.00 Perf YTD-76.24%
Dividend Est.- P/FCF- EPS past 5Y- ROI- 52W High-99.58% Beta2.15
Dividend TTM- Quick Ratio0.12 Sales past 5Y0.00% Gross Margin- 52W Low12.41% ATR (14)1.14
Dividend Ex-Date- Current Ratio0.12 EPS Y/Y TTM-523.46% Oper. Margin- RSI (14)33.72 Volatility40.19% 24.61%
Employees7 Debt/Eq- Sales Y/Y TTM- Profit Margin- Recom- Target Price-
Option/ShortNo / Yes LT Debt/Eq- EPS Q/Q-2314.66% Payout- Rel Volume1.14 Prev Close1.78
Sales Surprise- EPS Surprise- Sales Q/Q- Earnings- Avg Volume3.30M Price1.63
SMA20-52.45% SMA50-74.02% SMA200-97.53% Trades Volume3,723,954 Change-8.43%
Feb-13-25 08:00AM
Feb-11-25 09:00AM
Feb-08-25 06:08AM
Feb-07-25 08:00AM
Jan-28-25 05:30AM
08:00AM Loading…
Jan-23-25 08:00AM
Jan-22-25 08:00AM
Dec-12-24 07:30AM
Nov-21-24 07:30AM
Nov-19-24 04:30PM
Nov-05-24 07:40AM
Nov-04-24 07:30AM
Nov-01-24 04:45PM
Aug-28-24 08:00AM
Aug-12-24 07:00AM
06:30AM Loading…
Aug-08-24 06:30AM
Jul-16-24 02:52PM
08:12AM
07:43AM
07:30AM
Jun-13-24 08:00AM
May-29-24 04:21PM
May-15-24 09:53AM
Mar-19-24 10:57AM
07:00AM
Mar-11-24 02:26PM
07:00AM
Jan-31-24 08:30AM
Nov-02-23 08:30AM
Oct-30-23 08:39AM
08:30AM Loading…
Oct-11-23 08:30AM
Oct-06-23 09:29AM
08:30AM
Sep-22-23 09:01AM
Sep-20-23 05:40PM
Sep-13-23 08:30AM
Sep-07-23 04:30PM
Aug-31-23 04:05PM
Aug-16-23 08:30AM
Conduit Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of clinical assets to address the unmet medical needs of patients, through exclusive relationships in the areas of autoimmune disease and idiopathic male infertility. The company is headquartered in Naples, FL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Nirland Ltd10% OwnerOct 03 '24Sale0.101,500,000156,4508,400,000Oct 07 07:38 PM
Nirland Ltd10% OwnerOct 04 '24Sale0.101,368,991140,4587,031,009Oct 07 07:38 PM
Nirland Ltd10% OwnerOct 07 '24Sale0.10939,00996,5306,092,000Oct 07 07:38 PM
Nirland Ltd10% OwnerOct 01 '24Sale0.111,250,000141,37510,233,177Oct 02 05:02 PM
Nirland Ltd10% OwnerSep 30 '24Sale0.121,016,823122,01911,483,177Oct 02 05:02 PM
Nirland Ltd10% OwnerOct 02 '24Sale0.10333,17734,2519,900,000Oct 02 05:02 PM
Regan AndrewDirectorJul 16 '24Sale0.3210,244,3923,246,4481,691,727Sep 19 05:01 PM
Regan AndrewDirectorJul 17 '24Sale0.261,514,100391,092177,627Sep 19 05:01 PM
Regan AndrewDirectorJul 12 '24Sale0.251,389,820343,42512,941,319Sep 19 05:01 PM
Regan AndrewDirectorJul 11 '24Sale0.29882,952260,25314,331,139Sep 19 05:01 PM
Regan AndrewDirectorJul 15 '24Sale0.251,005,200248,38511,936,119Sep 19 05:01 PM
Regan AndrewDirectorJul 10 '24Sale0.33150,00050,07015,214,091Sep 19 05:01 PM
Regan AndrewDirectorJul 09 '24Sale0.4477,68133,85315,364,091Sep 19 05:01 PM
Regan AndrewDirectorJul 08 '24Sale0.5135,92318,32115,441,772Sep 19 05:01 PM
Regan AndrewDirectorJul 03 '24Sale0.641,00064015,477,695Sep 19 05:01 PM